These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7076853)

  • 1. An abnormal triglyceride-rich lipoprotein containing excess sialylated apolipoprotein C-III.
    Holdsworth G; Stocks J; Dodson P; Galton DJ
    J Clin Invest; 1982 Apr; 69(4):932-9. PubMed ID: 7076853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of heparin-induced lipolysis on the distribution of apolipoprotein e among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase.
    Rubinstein A; Gibson JC; Paterniti JR; Kakis G; Little A; Ginsberg HN; Brown WV
    J Clin Invest; 1985 Feb; 75(2):710-21. PubMed ID: 3973025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitation of human apolipoprotein C-III and its subspecie by radioimmunoassay and analytical isoelectric focusing: abnormal plasma triglyceride-rich lipoprotein apolipoprotein C-III subspecie concentrations in hypertriglyceridemia.
    Kashyap ML; Srivastava LS; Hynd BA; Gartside PS; Perisutti G
    J Lipid Res; 1981 Jul; 22(5):800-10. PubMed ID: 7288286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertriglyceridaemia associated with an abnormal triglyceride-rich lipoprotein carrying excess apolipoprotein C-III-2.
    Stocks J; Holdsworth G; Galton D
    Lancet; 1979 Sep; 2(8144):667-71. PubMed ID: 90760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of slow-release bezafibrate on serum lipids, lipoproteins, apolipoproteins, and postheparin lipolytic activities in patients with type IV and type V hypertriglyceridemia.
    Saku K; Sasaki J; Arakawa K
    Clin Ther; 1989; 11(3):331-40. PubMed ID: 2743372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal preponderance of sialylated apolipoprotein CIII in triglyceride rich lipoproteins in type V hyperlipoproteinemia.
    Kashyap ML; Hynd BA; Robinson K; Gartside PS
    Metabolism; 1981 Feb; 30(2):111-8. PubMed ID: 7464559
    [No Abstract]   [Full Text] [Related]  

  • 7. An abnormal triglyceride-rich lipoprotein carrying excess apolipoprotein C-II.
    Stocks J; Holdsworth G; Dodson P; Galton DJ
    Atherosclerosis; 1981; 38(1-2):1-9. PubMed ID: 7470192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of apolipoprotein(a) in the plasma from patients with lipoprotein lipase deficiency and with type III hyperlipoproteinemia. No evidence for a triglyceride-rich precursor of lipoprotein(a).
    Sandholzer C; Feussner G; Brunzell J; Utermann G
    J Clin Invest; 1992 Nov; 90(5):1958-65. PubMed ID: 1430218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of desialylation of very low-density lipoproteins on their catabolism by lipoprotein lipase.
    Stoline AM; Saku K; Hynd BA; Kashyap ML
    Metabolism; 1985 Jan; 34(1):30-5. PubMed ID: 3965860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of human plasma apolipoproteins C-I, C-II, and C-III by radioimmunoassays.
    Bren ND; Rastogi A; Kottke BA
    Mayo Clin Proc; 1993 Jul; 68(7):657-64. PubMed ID: 8350639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
    Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P
    Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The distribution of apo C-II and apo C-III in very low density lipoproteins of normal and type IV subjects.
    Catapano AL
    Atherosclerosis; 1980 Apr; 35(4):419-24. PubMed ID: 7378122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased prevalence of apolipoprotein E4 in type V hyperlipoproteinemia.
    Ghiselli G; Schaefer EJ; Zech LA; Gregg RE; Brewer HB
    J Clin Invest; 1982 Aug; 70(2):474-7. PubMed ID: 7096573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of lipoprotein lipase by apolipoprotein C-II is modulated by the COOH terminal region of apolipoprotein C-III.
    Catapano AL
    Chem Phys Lipids; 1987 Oct; 45(1):39-47. PubMed ID: 3446410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and characterization of lipoprotein lipase activators from bovine blood serum.
    Sundheim G; Zimmer TL; Astrup HN
    J Dairy Sci; 1983 Mar; 66(3):407-14. PubMed ID: 6841745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of apolipoproteins B-48 and B-100 of triglyceride-rich lipoproteins in normal and lipoprotein lipase-deficient humans.
    Stalenhoef AF; Malloy MJ; Kane JP; Havel RJ
    Proc Natl Acad Sci U S A; 1984 Mar; 81(6):1839-43. PubMed ID: 6584917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoproteins C in very low density lipoproteins (VLDL) in idiopathic hyperlipoproteinaemia.
    Kłosiewicz-Latoszek L; Naruszewicz M; Szostak WB; Nowicka G
    Acta Physiol Pol; 1982; 33(1-2):57-63. PubMed ID: 7158381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.
    Ginsberg HN; Le NA; Goldberg IJ; Gibson JC; Rubinstein A; Wang-Iverson P; Norum R; Brown WV
    J Clin Invest; 1986 Nov; 78(5):1287-95. PubMed ID: 3095375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects.
    Packard CJ; Munro A; Lorimer AR; Gotto AM; Shepherd J
    J Clin Invest; 1984 Dec; 74(6):2178-92. PubMed ID: 6511922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein C-II deficiency syndrome. Clinical features, lipoprotein characterization, lipase activity, and correction of hypertriglyceridemia after apolipoprotein C-II administration in two affected patients.
    Baggio G; Manzato E; Gabelli C; Fellin R; Martini S; Enzi GB; Verlato F; Baiocchi MR; Sprecher DL; Kashyap ML
    J Clin Invest; 1986 Feb; 77(2):520-7. PubMed ID: 3944267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.